Is myelin basic protein a potential biomarker of brain cancer?

被引：7
作者：
Zavialova, M. G. [1 ]
Shevchenko, V. E. [2 ]
Nikolaev, E. N. [1 ,3 ]
Zgoda, V. G. [1 ]
机构：
[1] Inst Biomed Chem IBMC, Moscow, Russia
[2] Blokhin Russian Canc Res Ctr, Moscow, Russia
[3] Skolkovo Inst Sci & Technol Skoltech, Skolkovo, Russia
来源：
EUROPEAN JOURNAL OF MASS SPECTROMETRY | 2017年 / 23卷 / 04期
基金：
俄罗斯科学基金会;
关键词：
Proteomics; pseudo-selected reaction monitoring; brain cancer; cerebral spinal fluid; myelin basic protein; CEREBROSPINAL-FLUID; MULTIPLE-SCLEROSIS; QUANTITATIVE PROTEOMICS; IDENTIFICATION; DISEASE; SAMPLES; DAMAGE;
D O I：
10.1177/1469066717719810
中图分类号：
O64 [物理化学（理论化学）、化学物理学]; O56 [分子物理学、原子物理学];
学科分类号：
070203 ; 070304 ; 081704 ; 1406 ;
摘要：
Myelin basic protein is a potential biomarker for the central nervous system diseases in which the myelin sheath is destroyed. Using pseudo-selected reaction monitoring and the method of standard additions, we have measured the myelin basic protein level in the cerebrospinal fluid of patients with neurotrauma (n = 6), chronic neurodegenerative diseases (n = 2) and brain cancer (n = 5). Myelin basic protein was detected only in four out of five cerebrospinal fluid samples of patients with brain cancer. The cerebrospinal fluid myelin basic protein level ranged from 3.7 to 8.8 ng ml(-1). We suggest that monitoring of myelin basic protein in cerebrospinal fluid can serve as a diagnostic test for the brain cancer.
引用
收藏
页码：192 / 196
页数：5
相关论文
共 26 条
  • [1] Identification of brain-enriched proteins in the cerebrospinal fluid proteome by LC-MS/MS profiling and mining of the Human Protein Atlas
    Begcevic, Ilijana
    Brinc, Davor
    Drabovich, Andrei P.
    Batruch, Ihor
    Diamandis, Eleftherios P.
    [J]. CLINICAL PROTEOMICS, 2016, 13
  • [2] Cerebrovascular Biomarker Profile Is Related to White Matter Disease and Ventricular Dilation in a LADIS Substudy
    Bjerke, Maria
    Jonsson, Michael
    Nordlund, Arto
    Eckerstrom, Carl
    Blennow, Kaj
    Zetterberg, Henrik
    Pantoni, Leonardo
    Inzitari, Domenico
    Schmidt, Reinhold
    Wallin, Anders
    [J]. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS EXTRA, 2014, 4 (03): : 385 - 394
  • [3] Assessing tissue damage in multiple sclerosis: a biomarker approach
    Burman, J.
    Zetterberg, H.
    Fransson, M.
    Loskog, A. Sl
    Raininko, R.
    Fagius, J.
    [J]. ACTA NEUROLOGICA SCANDINAVICA, 2014, 130 (02): : 81 - 89
  • [4] Targeted Peptide Measurements in Biology and Medicine: Best Practices for Mass Spectrometry- based Assay Development Using a Fit- for- Purpose Approach
    Carr, Steven A.
    Abbatiello, Susan E.
    Ackermann, Bradley L.
    Borchers, Christoph
    Domon, Bruno
    Deutsch, Eric W.
    Grant, Russell P.
    Hoofnagle, Andrew N.
    Huettenhain, Ruth
    Koomen, John M.
    Liebler, Daniel C.
    Liu, Tao
    MacLean, Brendan
    Mani, D. R.
    Mansfield, Elizabeth
    Neubert, Hendrik
    Paulovich, Amanda G.
    Reiter, Lukas
    Vitek, Olga
    Aebersold, Ruedi
    Anderson, Leigh
    Bethem, Robert
    Blonder, Josip
    Boja, Emily
    Botelho, Julianne
    Boyne, Michael
    Bradshaw, Ralph A.
    Burlingame, Alma L.
    Chan, Daniel
    Keshishian, Hasmik
    Kuhn, Eric
    Kinsinger, Christopher
    Lee, Jerry S. H.
    Lee, Sang-Won
    Moritz, Robert
    Oses-Prieto, Juan
    Rifai, Nader
    Ritchie, James
    Rodriguez, Henry
    Srinivas, Pothur R.
    Townsend, R. Reid
    Van Eyk, Jennifer
    Whiteley, Gordon
    Wiita, Arun
    Weintraub, Susan
    [J]. MOLECULAR & CELLULAR PROTEOMICS, 2014, 13 (03) : 907 - 917
  • [5] Quantitative Proteomic Analysis of Human Substantia Nigra in Alzheimer's Disease, Huntington's Disease and Multiple Sclerosis
    Chen, Sheng
    Lu, Frances Fangjia
    Seeman, Philip
    Liu, Fang
    [J]. NEUROCHEMICAL RESEARCH, 2012, 37 (12) : 2805 - 2813
  • [6] Novel insights into the development and maintenance of the blood-brain barrier
    Engelhardt, Britta
    Liebner, Stefan
    [J]. CELL AND TISSUE RESEARCH, 2014, 355 (03) : 687 - 699
  • [7] Molecular biomarkers in cerebrospinal fluid of multiple sclerosis patients
    Fitzner, Brit
    Hecker, Michael
    Zettl, Uwe Klaus
    [J]. AUTOIMMUNITY REVIEWS, 2015, 14 (10) : 903 - 913
  • [8] Advances in high-resolution quantitative proteomics: implications for clinical applications
    Gallien, Sebastien
    Domon, Bruno
    [J]. EXPERT REVIEW OF PROTEOMICS, 2015, 12 (05) : 489 - 498
  • [9] Golfinos JG, 1997, CLIN CANCER RES, V3, P799
  • [10] Cerebrospinal Fluid Myelin Basic Protein Is Frequently Ordered but Has Little Value A Test Utilization Study
    Greene, Dina N.
    Schmidt, Robert L.
    Wilson, Andrew R.
    Freedman, Mark S.
    Grenache, David G.
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2012, 138 (02) : 262 - 272
123